[Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
Kostowski
W
W
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D004298:Dopamine / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D018818:Fenoldopam; D006801:Humans; D009131:Muscle, Smooth, Vascular; D010479:Pergolide; D019257:Quinpirole; D011954:Receptors, Dopamine / Q000187:drug effects*; D014665:Vasodilator Agents
D000316:Adrenergic alpha-Agonists; D001552:Benzazepines; D004873:Ergolines; D011954:Receptors, Dopamine; D014665:Vasodilator Agents; D019257:Quinpirole; D010479:Pergolide; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D018818:Fenoldopam; D004298:Dopamine
Agoniści obwodowych receptorów dopaminergicznych jako potencjalne leki w chorobach układu krazenia.